ArticleScientific reports2026
Changes in macular structure after removal of epiretinal membrane in combined hamartomas of the retina and retinal pigment epithelium.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study investigates the effect of epiretinal membrane (ERM) removal in the combined hamartomas of the retina and retinal pigment epithelium (CHRRPE) patients. In this retrospective, comparative case series, 15 CHRRPE patients were included. Six patients received ERM surgery (operation group) and 9 patients were observed (observation group). The differences of age at diagnosis and the severity of ERM were not statistically significant for the operation and observation group at initial diagnosis. The change in central macular thickness (CMT), foveo-papillary distance (FPD) and best corrected visual acuity (BCVA) were analyzed for both groups at initial and final follow-up visits. In the operation group, CMT significantly decreased (initial 480 ± 151 μm VS final 365 ± 59 μm; P = 0.036), while FPD significantly increased (P = 0.031). BCVA significantly improved at the final follow-up in operation group (P = 0.031). In the observation group, FPD decreased significantly (P = 0.012) and BCVA did not change significantly (P = 0.438). Removal of ERM may be beneficial in normalizing macular anatomy and may be effective in preventing visual deterioration in patients with ERM associated with CHRRPE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.